Julien Marlet

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Paul Bastard, Adrian Gervais, Jérémie Rosain et al. · Science Immunology · 2021 · 631 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort

Nadège Néant, Guillaume Lingas, Quentin Le Hingrat et al. · Proceedings of the National Academy of Sciences · 2021 · 254 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to December 2020

Antonin Bal, Grégory Destras, Alexandre Gaymard et al. · Eurosurveillance · 2021 · 230 citations · Full text

Life Sciences, Genetics, Infectious Diseases +13

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jérémy Manry, Paul Bastard, Adrian Gervais et al. · Proceedings of the National Academy of Sciences · 2022 · 193 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism

Hélène Blasco, C. Bessy, Laurent Plantier et al. · Scientific Reports · 2020 · 150 citations · Full text

Life Sciences, Infectious Diseases, Molecular Medicine +17